Correlation Between ArcelorMittal and Summit Therapeutics

Can any of the company-specific risk be diversified away by investing in both ArcelorMittal and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ArcelorMittal and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ArcelorMittal SA ADR and Summit Therapeutics PLC, you can compare the effects of market volatilities on ArcelorMittal and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ArcelorMittal with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ArcelorMittal and Summit Therapeutics.

Diversification Opportunities for ArcelorMittal and Summit Therapeutics

0.16

Correlation Coefficient

ArcelorMittal  Summit Therapeutics

Average diversification

The 3 months correlation between ArcelorMittal and Summit is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding ArcelorMittal SA ADR and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and ArcelorMittal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ArcelorMittal SA ADR are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of ArcelorMittal i.e., ArcelorMittal and Summit Therapeutics go up and down completely randomly.

Pair Corralation between ArcelorMittal and Summit Therapeutics

Allowing for the 90-day total investment horizon ArcelorMittal SA ADR is expected to generate 0.41 times more return on investment than Summit Therapeutics. However, ArcelorMittal SA ADR is 2.44 times less risky than Summit Therapeutics. It trades about -0.05 of its potential returns per unit of risk. Summit Therapeutics PLC is currently generating about -0.05 per unit of risk. If you would invest  2,355  in ArcelorMittal SA ADR on October 15, 2024 and sell it today you would lose (149.00) from holding ArcelorMittal SA ADR or give up 6.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

ArcelorMittal SA ADR  vs.  Summit Therapeutics PLC

ArcelorMittal SA ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ArcelorMittal SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, ArcelorMittal is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Summit Therapeutics PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with ArcelorMittal and Summit Therapeutics

The main advantage of trading using opposite ArcelorMittal and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ArcelorMittal position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.

The idea behind ArcelorMittal SA ADR and Summit Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.